Medication Affordability and Patent Integrity Act

# Medication Affordability and Patent Integrity Act (S 2658) **What the Bill Would Do** This bill aims to make prescription medications more affordable while protecting pharmaceutical patent rights. Based on its title and sponsors, it would likely introduce measures to reduce drug prices for consumers while maintaining protections for drug manufacturers' intellectual property. The specific mechanisms aren't detailed in the available information, but bills with this title typically address balancing act between affordability for patients and incentives for pharmaceutical innovation. **Who It Affects** The bill would primarily impact patients who purchase prescription medications, as well as pharmaceutical companies that develop and sell drugs. It could also affect insurance companies and healthcare providers.

The bill is sponsored by Senator Margaret Wood Hassan (D-NH), suggesting it may be particularly relevant to her constituents and the broader American public struggling with medication costs. **Current Status** As of now, S 2658 remains in committee, meaning it hasn't advanced to a full Senate vote. The bill was introduced in the 119th Congress but has not yet become law. For the most current information on this bill's progress, you can check Congress.gov.